Capitalization 9.4B 1.29B 1.78B P/E ratio 2024 *
17.4x
P/E ratio 2025 * 16.5x
Enterprise value 12.74B 1.75B 2.41B EV / Sales 2024 *
1.52x
EV / Sales 2025 * 1.44x
Free-Float
59.17%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.88%
Current month+2.62%
3 months-15.41%
6 months-14.01%
Current year-26.18%
More quotes
1 week
3.10
Extreme 3.1
3.22
1 month
3.01
Extreme 3.01
3.22
Current year
3.01
Extreme 3.01
4.39
1 year
3.01
Extreme 3.01
5.35
3 years
3.01
Extreme 3.01
9.90
5 years
3.01
Extreme 3.01
9.90
10 years
2.92
Extreme 2.92
10.93
More quotes
Manager TitleAgeSince
Chief Executive Officer 60 -
Director of Finance/CFO 49 -
Director/Board Member 55 -
Director TitleAgeSince
Founder 59 96-09-22
Chief Executive Officer 60 -
Director of Finance/CFO 49 -
More insiders

Alternative Medicine

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.88%0.00%-39.46%-29.02% 1.32B
-5.15%-9.23%-1.51%+49.27% 4.76B
-2.91%-2.11%-36.61%-17.70% 3.63B
-4.28%+0.60%-18.14%+20.92% 3.22B
-4.30%-1.01%-10.12%-6.69% 2.73B
-1.79%-3.19%-26.16%-27.60% 2.28B
-5.06%-6.10%+47.55%+93.50% 1.82B
-3.32%-1.89%-19.89%-35.67% 1.41B
-5.18%-7.23%+20.97%+55.14% 1.4B
+0.69%-1.35%+4.29%-3.21% 1.34B
Average -3.32%-2.07%-7.91%+9.89% 2.39B
Weighted average by Cap. -3.65%-2.25%-10.21%+13.03%
See all sector performances

Financials

Ratios2024 *2025 *
Net sales 6.19B 851M 1.17B 6.51B 895M 1.23B
Net income 533M 73.27M 101M 557M 76.57M 105M
Net Debt - -
More financial data * Estimated data
Logo Tianjin Chase Sun Pharmaceutical Co.,Ltd
Tianjin Chase Sun Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Company's main products include Chinese traditional formula granules, Xuebijing injection, fasudil hydrochloride injection, low molecular weight heparin calcium injection, bulk drugs and excipient, among others. The Company also provides medical apparatus and instrument. The Company distributes its products in domestic market and to overseas markets.
Employees
0
Calendar
More about the company
Date Price Change Volume
24-07-22 3.130 ¥ -1.88% 21 613 750
24-07-22 3.190 ¥ 0.00% 24,264,550
24-07-19 3.190 ¥ -0.62% 24,168,150
24-07-18 3.210 ¥ +2.23% 40,469,600
24-07-17 3.140 ¥ +0.64% 19,847,100

End-of-day quote Shenzhen S.E., July 22, 2024

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.130CNY
Average target price
4.000CNY
Spread / Average Target
+27.80%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300026 Stock